Aevis Victoria SA (AEVS) Earnings Call Transcripts
Aevis Victoria SA's Latest Earnings Call - April 2, 2026
Aevis Victoria SA reported its 2025 annual results, highlighting a 13.5% increase in turnover, driven by acquisitions such as Spital Zofingen. However, EBITDA declined due to the absence of profits from previous sales of participations. The company emphasized its focus on NAV, which increased by 7.8%, and noted a significant share price discount. Management provided guidance for 2026, projecting an EBITDAR margin increase from 15.9% to over 20.5%, driven by cost optimizations and acquisitions. The company plans to resume dividends in 2026, following restrictions due to COVID-related government aid.
Reported metrics
| Metric | Value |
|---|---|
| Turnover | +13.5% (beat) |
| EBITDA | Declined (miss) |
| NAV per Share | +7.8% (beat) |
| Swiss Medical Network Revenue | +22% (beat) |
| Hospitality Organic Growth | 4.5% (beat) |
| Free Cash Flow | CHF 129 million (beat) |
Guidance from management
Management expects EBITDAR margins to increase from 15.9% to over 20.5% in 2026, driven by cost optimizations and the ramp-up of acquired assets. Organic growth is projected at 2-3% per annum.
What management said
Okay. So thank you very much for your attention. And we, of course, through our Investor Relations, are always ready to meet and to discuss investment in our company. Thank you very much for your attention, and have a good day to everybody.
What analysts pressed on
Analysts questioned the financing of the See-Spital, Horgen acquisition and the potential impact of geopolitical events on the hospitality segment. There were also inquiries about the potential IPO of Infracore and the resumption of dividends.
Main topics on the call
- Acquisition Impact — The acquisition of Spital Zofingen and Centro Medico contributed to a 22% revenue increase in the Swiss Medical Network, though margins were diluted due to lower initial margins of these acquisitions. Management views th...
- Net Asset Value (NAV) Focus — Aevis Victoria's NAV per share increased by 7.8%, reflecting value creation across its portfolio. The company noted a substantial discount between NAV and the current share price, close to 50%, indicating potential under...
- Margin Pressure and Improvement Strategy — EBITDAR margins declined from 16.6% to 15.9% due to acquisition-related dilution. However, the underlying business improved its EBITDAR margin from 16.6% to 17.2%. Management expects margins to reach 20.5% in 2026 throug...
- Integrated Care Strategy — The company is expanding its integrated care model, which aims to transition from fee-for-service to value-based care. Management highlighted the success of this model in reducing costs by 11% in its first year in certai...
Read the full Aevis Victoria SA transcript (April 2, 2026) → Summary generated from the call transcript; every figure above is stated by management on the record.
About Aevis Victoria SA
Aevis Victoria SA (AEVS) is a publicly listed company in the Health Care Providers and Services industry, within the Health Care sector. It trades on SWX and is based in CH. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 8 calls on record spanning March 27, 2020 to April 2, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.
Earnings Call History
EarningsCalls.dev has 8 Aevis Victoria SA earnings call transcripts on record, spanning March 27, 2020 to April 2, 2026. Based on this history, Aevis Victoria SA reports annually. The most recent call on file is dated April 2, 2026. The full list is below — each row opens the complete, free-to-read transcript.
- Ticker
- AEVS
- Exchange
- SWX
- Country
- CH
- Sector
- Health Care
- Calls on record
- 8
- First call
- March 27, 2020
- Most recent
- April 2, 2026
- Reporting cadence
- annually
| Quarter | Date | |
|---|---|---|
| Earnings Calls | Apr 2, 2026 | Read transcript → |
| Earnings Calls | Apr 3, 2025 | Read transcript → |
| Earnings Calls | Mar 28, 2024 | Read transcript → |
| Earnings Calls | Mar 31, 2023 | Read transcript → |
| Earnings Calls | Mar 31, 2022 | Read transcript → |
| Earnings Calls | Mar 26, 2021 | Read transcript → |
| Earnings Calls | Sep 18, 2020 | Read transcript → |
| Earnings Calls | Mar 27, 2020 | Read transcript → |